Discover the future of pharmacy. Explore, learn and earn 1.50 CE credits. Register now!
Continuing the Conversation: OTC Contraception in Pharmacy Practice
September 17, 2024 | 1:00 PM & 8:00 PM ET
View More
Navigating the Complexities of Oncologic Immunotherapy and Vascular Endothelial Growth Factor Receptor Tyrosin...
1.5 Credit / Oncology
View More
AMD and DME: Highlighting the Role of the Pharmacist in Patient Education and Counseling
1.0 Credit / Ophthalmology/Optometry
View More
Directions in Oncology Pharmacy® 2024: Midwest
Saturday, September 21, 2024
View More
Examining Current and Emerging Therapies to Slow Progression of Chronic Kidney Disease
1.0 Credit / Endocrinology, Diabetes, and Metabolism, Nephrology
View More
Individualizing Care for Patients With Heart Failure: The Role of the Pharmacist in Optimizing Education and I...
1.0 Credit / Cardiology
View More
Best Practices for the Integration of Continuous Glucose Monitoring Devices Across Community Pharmacy Settings
September 24, 2024 | 1:00 PM ET
View More
Maximizing Patient Outcomes in Ophthalmologic Diseases: How Managed Care Professionals Play a Key Role in Faci...
1.0 Credit / Ophthalmology/Optometry
View More
FDA Approves Lebrikizumab-lbkz for Moderate-to-Severe Atopic Dermatitis
September 16th 2024Lebrikizumab-lbks is a targeted treatment that addresses the root cause of atopic dermatitis; by reducing inflammation throughout the body, it can help alleviate the dry, itchy, and irritated skin that often characterizes the condition.